The other study, by Wu et al [85], evaluated whether combined anti-TNFα etanercept and gemcitabine improved the survival of patients with advanced pancreatic cancer with respect to gemcitabine alone. This evidence concerns the gene TNF and familial pancreatic carcinoma.